Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation RLTs.
In the US, diagnosed prevalence is anticipated to increase across all opioid addiction patient segments. Credit: Iryna Imago ...
Its growth is attributed to the introduction of new treatments. The chronic obstructive pulmonary disease (COPD) market is ...
Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...
Experts explored the latest trends, approvals, and pipeline developments in cell and gene therapies, rare disease, immunology ...
In the United States, more than 10 million people above the age of 40 live with chronic obstructive pulmonary disease (COPD), a chronic lung disease that limits air flow and causes ...